Literature DB >> 18159352

Susceptibility of community Gram-negative urinary tract isolates to mecillinam and other oral agents.

T Mazzulli1, M Skulnick, G Small, W Marshall, D J Hoban, G G Zhanel, S Finn, D E Low.   

Abstract

OBJECTIVE: To determine the susceptibility of community outpatient Gram-negative urinary tract isolates to mecillinam and other commonly used oral agents. DESIGN AND
SETTING: The study was a laboratory-based study of consecutive Gram-negative urinary tract isolates. Only those isolates considered to be significant pathogens were included in the study. Susceptibility testing was performed using agar dilution methodology following guidelines published by the National Committee for Clinical Laboratory Standards. POPULATION STUDIED: Outpatients presenting to a family physician or clinic with signs or symptoms suggestive of a urinary tract infection were included in the study. MAIN
RESULTS: Of 2000 consecutive community isolates (91.8% Escherichia coli, 3.9% Klebsiella species, 2.0% Proteus species, 2.3% others), in vitro susceptibilities were: mecillinam 98.8%, ampicillin 77.0%, ciprofloxacin 100%, trimethoprim/sulfamethoxazole 91.6% and nitrofurantoin 95.4%. Susceptibility to mecillinam was significantly better than all other agents except ciprofloxacin (P<0.001, McNemar's test). Organisms with reduced susceptibility to mecillinam included Citrobacter species, Pseudomonas aeruginosa and Providencia species.
CONCLUSIONS: Community Gram-negative urinary tract isolates remain highly sensitive to mecillinam and ciprofloxacin, but a significant number have developed resistance to trimethoprim/sulfamethoxazole. Further studies are required to determine the clinical significance of these results.

Entities:  

Keywords:  Gram-negative organisms; Outpatients; Urinary tract infections

Year:  2001        PMID: 18159352      PMCID: PMC2094837          DOI: 10.1155/2001/601743

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  15 in total

1.  Are resistance patterns in uropathogens published by microbiological laboratories valid for general practice?

Authors:  A Baerheim; A Digranes; S Hunskaar
Journal:  APMIS       Date:  1999-07       Impact factor: 3.205

2.  Survey on antibiotic usage in the treatment of urinary tract infections.

Authors:  K G Naber
Journal:  J Antimicrob Chemother       Date:  2000-09       Impact factor: 5.790

Review 3.  Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era.

Authors:  T F Patterson; V T Andriole
Journal:  Infect Dis Clin North Am       Date:  1997-09       Impact factor: 5.982

4.  Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.

Authors:  D A Talan; W E Stamm; T M Hooton; G J Moran; T Burke; A Iravani; J Reuning-Scherer; D A Church
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

5.  The mechanism of action of mecillinam.

Authors:  B G Spratt
Journal:  J Antimicrob Chemother       Date:  1977-07       Impact factor: 5.790

Review 6.  Diagnosis and treatment of uncomplicated urinary tract infection.

Authors:  T M Hooton; W E Stamm
Journal:  Infect Dis Clin North Am       Date:  1997-09       Impact factor: 5.982

7.  Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women.

Authors:  K Gupta; D Scholes; W E Stamm
Journal:  JAMA       Date:  1999-02-24       Impact factor: 56.272

8.  A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group.

Authors:  G G Zhanel; J A Karlowsky; G K Harding; A Carrie; T Mazzulli; D E Low; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

9.  Synergy of mecillinam, a beta-amidinopenicillanic acid derivative, combined with beta-lactam antibiotics.

Authors:  J C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

10.  Pivmecillinam in treatment of Staphylococcus saprophyticus urinary tract infections.

Authors:  M Granlund; E Landgren; C Henning
Journal:  Scand J Infect Dis       Date:  1983
View more
  7 in total

Review 1.  Uncomplicated urinary tract infection in women. Current practice and the effect of antibiotic resistance on empiric treatment.

Authors:  Lindsay Nicolle; Peter A M Anderson; John Conly; Thomas C Mainprize; Jamie Meuser; J Curtis Nickel; Vyta M Senikas; George G Zhanel
Journal:  Can Fam Physician       Date:  2006-05       Impact factor: 3.275

2.  Community-acquired antibiotic resistance in urinary isolates from adult women in Canada.

Authors:  Warren J McIsaac; Tony Mazzulli; Joanne Permaul; Rahim Moineddin; Donald E Low
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-11       Impact factor: 2.471

3.  Uropathogen antibiotic resistance in adult women presenting to family physicians with acute uncomplicated cystitis.

Authors:  Warren J McIsaac; Tony Mazzulli; Rahim Moineddin; Janet Raboud; Susan Ross
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-09       Impact factor: 2.471

4.  Improved detection of microbiological pathogens: role of partner and non-governmental organizations.

Authors:  Michael Owusu; Bernard Nkrumah; Godfred Acheampong; Ebenezer Kofi Mensah; Abass Abdul-Karim Komei; Festus Kofi Sroda; Sambian David; Shannon Emery; Lucy Maryogo Robinson; Kwame Asante; David Opare
Journal:  BMC Infect Dis       Date:  2021-03-25       Impact factor: 3.090

5.  Altering Microbiomes with Hydroxyapatite Nanoparticles: A Metagenomic Analysis.

Authors:  Vuk Uskoković; Victoria M Wu
Journal:  Materials (Basel)       Date:  2022-08-24       Impact factor: 3.748

Review 6.  Role of Old Antibiotics in the Era of Antibiotic Resistance. Highlighted Nitrofurantoin for the Treatment of Lower Urinary Tract Infections.

Authors:  Maria Jose Munoz-Davila
Journal:  Antibiotics (Basel)       Date:  2014-02-10

7.  Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012.

Authors:  Tiffany R Keepers; Marcela Gomez; Chris Celeri; Kevin M Krause; Donald Biek; Ian Critchley
Journal:  Infect Dis Ther       Date:  2017-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.